Division of Cardiology, Ospedale Maggiore della Carità, Eastern Piedmont University, Novara, Italy.
JACC Cardiovasc Interv. 2011 Oct;4(10):1079-84. doi: 10.1016/j.jcin.2011.08.004.
The purpose of this study was to investigate the effects of increasing dose of intracoronary adenosine on fractional flow reserve (FFR) measurement.
FFR is a validated method for the assessment of the severity of coronary artery stenosis. It is based on the change in the pressure gradient across the stenosis after the achievement of maximal hyperemia of the coronary microcirculation that may be obtained by either intracoronary bolus or intravenous infusion of adenosine. No study has explored so far the effects of very high doses of intracoronary adenosine on FFR.
FFR was assessed in 46 patients with 50 intermediate lesions during cardiac catheterization by pressure-recording guidewire (PrimeWire, Volcano, San Diego, California). FFR was calculated as the ratio of the distal coronary pressure to the aortic pressure at hyperemia. Increasing doses of adenosine were administrated (60, 120, 180, 360, and 720 μg) as intracoronary boluses. Exclusion criteria were: 1) allergy to adenosine; 2) baseline bradycardia (heart rate <50 beats/min); 3) hypotension (blood pressure <90 mm Hg); and 4) refusal to provide signed informed consent.
High doses of intracoronary adenosine were well tolerated, with no major side effects. Increasing doses up to 720 μg progressively decreased FFR values and increased the percentage of patients showing an FFR <0.75. Among angiographic parameters, both percent stenosis and lesion length were independently associated with lower FFR values.
This study shows that high doses of intracoronary adenosine (up to 720 μg) increased the sensitivity of FFR in the detection of hemodynamically relevant coronary stenoses. Furthermore, lesion length and stenosis severity were independent angiographic determinants of FFR.
本研究旨在探讨冠状动脉内腺苷剂量增加对血流储备分数(FFR)测量的影响。
FFR 是评估冠状动脉狭窄严重程度的一种经过验证的方法。它基于冠状动脉微循环最大充血后狭窄处压力梯度的变化,这种充血可以通过冠状动脉内推注或静脉内输注腺苷来实现。目前尚无研究探讨非常高剂量的冠状动脉内腺苷对 FFR 的影响。
在心脏导管检查期间,通过压力记录导丝(PrimeWire,Volcano,圣地亚哥,加利福尼亚州)评估 46 例 50 例中度病变患者的 FFR。FFR 计算为充血时远端冠状动脉压力与主动脉压力的比值。以冠状动脉内推注方式给予递增剂量的腺苷(60、120、180、360 和 720μg)。排除标准为:1)对腺苷过敏;2)基础心动过缓(心率<50 次/分);3)低血压(血压<90mmHg);4)拒绝提供书面知情同意书。
高剂量的冠状动脉内腺苷耐受性良好,无重大不良反应。递增剂量至 720μg 逐渐降低 FFR 值,并增加 FFR<0.75 的患者比例。在血管造影参数中,狭窄程度百分比和病变长度均与较低的 FFR 值独立相关。
本研究表明,高剂量的冠状动脉内腺苷(高达 720μg)增加了 FFR 检测血流动力学相关冠状动脉狭窄的敏感性。此外,病变长度和狭窄严重程度是 FFR 的独立血管造影决定因素。